Lexpos News

/Lexpos News/

MHRA Class 4 Medicines Defect Notification: Tuzulby prolonged-release chewable tablets (Neuraxpharm UK Ltd)

MHRA Class 4 Medicines Defect Notification: Tuzulby prolonged-release chewable tablets (Neuraxpharm UK Ltd) Drug alert number: EL(26)A/36 Date issued: 23 July 2026 Neuraxpharm UK Ltd has informed the MHRA of missing safety information in the Patient Information Leaflet (PIL) and Summary of Product Characteristics (SmPC) for certain batches of Tuzulby prolonged release 20mg, 30mg and [...]

The post MHRA Class 4 Medicines Defect Notification: Tuzulby prolonged-release chewable tablets (Neuraxpharm UK Ltd) appeared first on Community Pharmacy England.

By |July 23rd, 2026|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Notification: Tuzulby prolonged-release chewable tablets (Neuraxpharm UK Ltd)

CPE reacts to business rates announcement

In response to the Prime Minister announcing a plan for changes to business rates, we have issued the following statement. Janet Morrison, Chief Executive of Community Pharmacy England, said: “We welcome the new Prime Minister’s review of business rates. Community pharmacies have not yet been mentioned in the measures to support high streets. Despite their [...]

The post CPE reacts to business rates announcement appeared first on Community Pharmacy England.

By |July 23rd, 2026|Lexpos News|Comments Off on CPE reacts to business rates announcement

July 2026 Price Concessions 4th Update

The Department of Health and Social Care (DHSC) has today (22/07/2026) confirmed the following list of price concessions for July 2026: Drug Pack size Price concession Aciclovir 400mg tablets 56 £2.67 Alfentanil 1mg/2ml solution for injection ampoules 10 £7.76 Amoxicillin 250mg/5ml oral suspension 100 £1.55 Apixaban 2.5mg tablets 60 £2.20 Atomoxetine 10mg capsules 28 £7.60 [...]

The post July 2026 Price Concessions 4th Update appeared first on Community Pharmacy England.

By |July 22nd, 2026|Lexpos News|Comments Off on July 2026 Price Concessions 4th Update

MHRA Drug Safety Update: Domperidone new contraindication

MHRA Drug Safety Update: Domperidone: new contraindication in patients with phaeochromocytoma due to the risk of severe hypertension. The product information has been updated for all domperidone products, to include a contraindication for patients with confirmed or suspected phaeochromocytoma (a rare tumour of the adrenal gland), due to the risk of episodes of severe hypertension. [...]

The post MHRA Drug Safety Update: Domperidone new contraindication appeared first on Community Pharmacy England.

By |July 21st, 2026|Lexpos News|Comments Off on MHRA Drug Safety Update: Domperidone new contraindication

July 2026 Price Concessions 3rd Update

The Department of Health and Social Care (DHSC) has today (21/07/2026) confirmed the following list of price concessions for July 2026: Drug Pack size Price concession Apixaban 5mg tablets 56 £1.39 Aqueous cream 500 £6.59 Aripiprazole 10mg tablets 28 £2.75 Ascorbic acid 500mg tablets 28 £45.62 Aspirin 75mg dispersible tablets 28 £2.95 Aspirin 75mg dispersible [...]

The post July 2026 Price Concessions 3rd Update appeared first on Community Pharmacy England.

By |July 21st, 2026|Lexpos News|Comments Off on July 2026 Price Concessions 3rd Update